Chemoresponse of de novo Acute Myeloid Leukemia to “7+3” Induction can Be Predicted by c-Myc-facilitated Cytogenetics

Background: Identifying patients with de novo acute myeloid leukemia (AML) who will probably respond to the “7 + 3” induction regimen remains an unsolved clinical challenge. This study aimed to identify whether c-Myc could facilitate cytogenetics to predict a “7 + 3” induction chemoresponse in de no...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsiao, Tzu-Hung, Wang, Ren Ching, Lu, Tsai-Jung, Shih, Chien-Hung, Su, Yu-Chen, Tsai, Jia-Rong, Jhan, Pei-Pei, Lia, Cai-Sian, Chuang, Han-Ni, Chang, Kuang-Hsi, Teng, Chieh-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061304/
https://www.ncbi.nlm.nih.gov/pubmed/33897436
http://dx.doi.org/10.3389/fphar.2021.649267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061304/
https://www.ncbi.nlm.nih.gov/pubmed/33897436
http://dx.doi.org/10.3389/fphar.2021.649267

Ejemplares similares